TP53 and breast carcinoma: We show that Δ133p53β is associated with poor prognosis in breast cancer, particularly in luminal A breast cancer patients who express WT TP53. This indicates that Δ133p53β, which is a physiological gene product of TP53, is a predictor of cancer cell invasion and increased risk of death.